×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Acasti Pharma to Attend BIO International Convention 2024
GlobeNewswire
PRINCETON, N.J., May 28, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (Nasdaq: ACST) (Acasti or the Company), a late-stage, biopharma company...
5 days ago
We're Keeping An Eye On Acasti Pharma's (NASDAQ:ACST) Cash Burn Rate
Simply Wall Street
Acasti Pharma's cash burn of US$14m is about 50% of its US$27m market capitalisation. That's high expenditure relative to the value of the...
1 month ago
Insider Stock Buying Reaches US$2.50m On Acasti Pharma
Yahoo Finance
In the last year, multiple insiders have substantially increased their holdings of Acasti Pharma Inc. ( NASDAQ:ACST...
2 weeks ago
Acasti Pharma (NASDAQ:ACST) Stock Price Crosses Below 200-Day Moving Average of $2.79
Defense World
Read Acasti Pharma (NASDAQ:ACST) Stock Price Crosses Below 200-Day Moving Average of $2.79 at Defense World.
5 days ago
Aker BioMarine acquires IP & equipment from Acasti Pharma Inc.
NutraIngredients-USA.com
Aker BioMarine ASA is consolidating intellectual property (IP) in the krill space, with the announcement that it has acquired krill-related...
7 months ago
After laying off most staff, Acasti insists it's still on track
Fierce Biotech
Laying off most of your workforce is normally a sign of a biotech in a death spiral, but Acasti's CEO is insistent the move has energized...
11 months ago
Acasti Pharma Announces 1-for-6 Reverse Stock Split
PR Newswire
The reverse stock split will become effective July 10, 2023 at 12:01 a.m. ET. The Company's common shares will trade on a split-adjusted basis...
10 months ago
Aker BioMarine acquires all krill-related patents from Acasti Pharma
Nutraceutical Business Review
Norway-based Aker BioMarine has acquired all krill-related patents, equipment, and scientific data from Acasti Pharma as a settlement...
7 months ago
The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom
Yahoo Finance
Novavax (NASDAQ:NVAX) stock was among the laggards in the race for the vaccine against COVID-19. Unsurprisingly, NVAX stock plunged from...
1 week ago
Acasti appoints WuXi to conduct STRIVE-ON trial
Clinical Trials Arena
The trial will include approximately 100 patients hospitalised for aneurysmal subarachnoid haemorrhage.
10 months ago